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Zusammenfassung  
Obwohl humane Parodontalligamentzellen (PDL) mehrere osteoblastäre Merkmale 
aufweisen, ist ihr Phänotyp noch immer nicht vollständig charakterisiert. Es bleibt eine 
ungeklärte Frage, ob sie ein ausdifferenziertes Zellstadium oder eine Zwischenstufe der 
zellulären Differenzierung darstellen und womöglich in ihrer phänotypischen Expression 
durch bestimmte Stimuli in eine eher fibroblastäre oder osteoblastäre Richtung beeinflusst 
werden können. 
Zur weiteren Erforschung der PDL-Zellcharakteristika wurden humane PDL Zellen der 
ersten und vierten Passage kultiviert und jeweils für fünf Tage mit FGF-2 bzw. BMP-7 
stimuliert. Anschließend wurde die Zellzahl mit Hilfe eines Zellzählers bestimmt. Der 
Einfluss auf die Differenzierung der Zellen wurde anhand des biochemischen Nachweises 
der alkalische-Phosphatase-Aktivität in Zelllysaten sowie mit Hilfe der Bestimmung des 
Osteokalzingehaltes des konditionierten Mediums bestimmt. Zur Beleuchtung der Frage, ob 
sich PDL-Zellen bei einer solchen Stimulation eher wie Fibroblasten oder wie Osteoblasten 
verhalten, dienten dermale Fibroblasten und Osteoblasten-ähnlichen Zellen (MG63) als 
Referenzzelllinien. 
Nach Ablauf der experimentellen Phase war die Zellzahl der Zellen der ersten Passage 
höher als die der vierten was auf ein großes Proliferationsvermögen dieser Zellen hinweist. 
Die Behandlung mit FGF-2 erhöhte die Zellzahl in beiden Passagen  wobei ALP und 
Osteocalcin Produktion unverändert blieben. Im Gegensatz dazu führte eine BMP-7 
Exposition zu einer Reduzierung der Zellzahl in beiden Passagen, während die ALP und 
Osteocalcin Produktion erhöht wurde. 
In dermalen Fibroblasten blieben die Differenzierungsparameter unverändert. MG63 Zellen 
verhielten sich ähnlich wie PDL Zellen. 
Diese Ergebnisse deuten darauf hin, dass 1) die Subkultivierung einen Einfluss auf die 
phänotypische Expression von humanen PDL Zellen hat, und 2) dass der Phänotyp dieser 
Zellen durch Wachstumsfaktoren modifiziert werden kann. 
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Introduction 
The periodontal ligament (PDL) is a specialized connective tissue interposed between the 
roots of teeth and the inner wall of the alveolar bone socket (Fig. 1). Its fibers form a 
meshwork that stretches out between the cementum and the bone. This meshwork provides 
both anchorage and cushioning of mechanical stresses which teeth are subjected to 
(Waddington and Embery 2001, Lecik et al. 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: the periodontal ligament binds the roots of the tooth to the alveolar bone providing 
anchorage. 
 
Identifying the biological properties of the cells residing within the periodontal ligament will 
help to understand the role these cells play in the various functions of the periodontal 
ligament, and will improve the success of clinical procedures such as orthodontic tooth 
movement (Basdra and Komposch 1997) and aid the therapeutical periodontal regeneration 
processes (Takayama et al. 1997). 
Within the mixed population of PDL cells, PDL fibroblasts represent the majority of cells. 
The exact phenotypic characteristics of PDL fibroblasts are still not well established. It 
remains a matter of debate whether these cells resemble a terminally differentiated cell type 
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of fibroblastic nature or whether they represent an intermediate maturation state which 
potentially can be directed toward a fibroblastic, cementoblastic or osteoblastic phenotype 
by certain growth factors.  
PDL fibroblasts exhibit several osteoblastic traits such as osteoblastic marker gene 
expression and enhanced alkaline phosphatase specific activity in response to 1,25-
(OH)2D3 (Basdra and Komposch 1997, Chen et al. 2002, Jackson et al. 2006, Wang et al. 
2007). Recently it has been demonstrated that PDL fibroblasts respond to parathyroid 
hormone in an osteoblast-like manner, too (Lossdörfer et. al. 2005, 2006 a, b, c). Thus, 
PDL cells are believed to be involved in the regulatory events in the course of periodontal 
repair processes following inflammatory periodontal disease or orthodontic tooth 
movement. 
 
In order to benefit from those properties and direct the differentiation process, several 
biological stimuli have been used. Among these factors, bone morphogenetic protein 
(BMP)-7, which is one of at least 15 structurally and functionally related BMPs that belong 
to the TGF-β superfamily of polypeptides, which was used to induce new bone formation in 
vivo and in vitro, as well as cementogenesis for bridging of periodontal bone defects 
(Ripamonti et al. 1996, Ripamonti and Reddi 1997, Franceschi et al. 2000, Krebsbach et al. 
2000, Nakashima and Reddi 2003). 
Fibroblast growth factor (FGF)-2, also known as basic FGF, which is a member of the FGF 
family, currently comprised of 19 related mitogenic proteins, stimulates the proliferation of 
all cells of mesodermal origin and many cells of neuroectodermal, ectodermal and 
endodermal origin (Fering et al. 1994, Coulier et al. 1997). Studies have also shown that 
FGF-2 induces the proliferation of bone marrow stromal cells (Hankemeier et al. 2005), 
gingival fibroblasts (Takayama et al. 2002), and PDL cells, while inhibiting PDL cell 
differentiation as evidenced by a reduction of alkaline phosphatase specific activity and 
mineralization in response to this growth factor (Okamoto et al. 1997, Murakami et al. 
1999).  
Previous studies showed that the cellular response to biological stimuli depends on cellular 
developmental age. Some in vitro studies employed fourth to eighth passage cells in their 
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experimental set up (Hou et al. 2007, Wescott et al. 2007). Others used different stages of 
confluence as a model of cellular maturation where increased alkaline phosphatase activity 
and osteocalcin production were associated with the confluent stage indicating a more 
mature phenotype as compared to pre-confluent cells (Chen et al. 2002, Jackson et al. 
2006, Wang et al. 2007). Recently this was also demonstrated in PDL cells (Lossdörfer et. 
al. 2005, 2006 a, b, c) 
However, it is unknown whether cells of different passages would respond differently to the 
same stimuli and whether those results could be compared to those involving different 
stages of confluence. Therefore, it was the aim of the present investigation to help 
identifying the traits of PDL cells by exposing them to BMP-7 and FGF-2 and to determine 
the role of the cell passage for the cellular response to such stimulation. 
 
Based on these considerations, we hypothesized that BMP-7 and FGF-2 would alter the 
PDL cells characteristics in that FGF-2 would enhance proliferation of the cells and 
minimally affect their differentiation, whereas we speculated that BMP-7 would inhibit 
proliferation but stimulate the differentiation of those cells towards a more osteoblastic 
phenotype. In addition, it was hypothesized that those effects would be dependent on cell 
passage as a model for cellular developmental age. 
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Materials and Methods 
PDL-Cell Culture 
Human periodontal ligament cells were obtained from premolar teeth of six healthy human 
donors aged between 12 and 14 years. The teeth showed no clinical signs of periodontitis 
and they had been extracted for orthodontic reasons, with informed parental consent and 
following a protocol approved by the ethics committee of the University of Bonn. 
Periodontal tissue was scraped from the middle third of the roots in order to avoid any 
contamination of the culture with gingival fibroblasts or pulp cells (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Obtaining the PDL cells by scraping the middle third of the tooth with a scalpel. 
 
 
Cells that grew from those explants were then cultured in DMEM containing 10% fetal 
bovine serum and 0.5% antibiotics (diluted from a stock solution containing 5000 U/ml 
penicillin and 5000 U/ml streptomycin; Biochrom AG, Berlin, Germany) at 37º C in an 
atmosphere of 100% humidity and 5% CO2. Medium was changed every 48 hours (Fig. 3). 
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Fig. 3: Cells in culture as seen under the microscope (Magnification x50). 
 
At  confluence, cells were detached from the culture flask using 0.05% (w/v) trypsin and 
0.05 mM (w/v) EDTA and transferred to 24-well-plates where they were subcultured at a 
density of 10000 cells/well (n=6) 
 
FGF-2 and BMP-7 Administration 
First and fourth passage cells were cultured for 5 days in the presence of either 50ng/ml 
FGF-2 or 50ng/ml BMP-7 (R&D Systems GmbH, Wiesbaden, Germany).  
FGF-2 vehicle was prepared using sterile phosphate-buffered saline containing 1µg/mL 
sodium heparin and 0.1% bovine serum albumin. BMP-7 vehicle on the other hand was 
prepared using 4mM HCL containing 0.1% bovine serum albumin. Vehicle-treated cultures 
for each treatment group served as controls. The media were changed after 24h and 
thereafter every 48h until the end of the experiment. 
 
Cell Culture of Dermal Fibroblasts and MG63-Osteoblast-like-Cells 
Commercially available human dermal fibroblasts of the 13th passage (1BR.3.G; European 
Collection of Cell Cultures) and 4th passage human MG63-osteoblast-like cells (European 
Collection of Cell Cultures) were used as reference cell lines for the characterization of the 
periodontal ligament cells, as well as for the comparison of periodontal ligament cell 
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response to FGF-2 and BMP-7 stimulation. The cells were cultured under same conditions 
as the PDL-cells and were treated with FGF-2 and BMP-7 accordingly. 
 
Effect of the Growth Factors on Proliferation 
After an experimental period of 5 days, the supernatant was collected for later osteocalcin 
analysis and the cells were released from the culture surface by trypsinization for 5 min at 
37°C. This reaction was stopped by the addition of DMEM containing 10% FBS. The cell 
suspension was then centrifuged, and the cell pellet was resuspended in 0.9% NaCl. 
Finally, the cell number was determined by the use of a cell counter (Moelab, Hilgen, 
Germany). Cells harvested in this manner exhibited >95% viability based on Trypan-blue 
exclusion. 
 
Effect of the Growth Factors on Differentiation 
Alkaline-phosphatase-specific activity was measured in lysates of isolated cells, as 
described previously (Bretaudiere and Spillman, 1984). The alkaline phosphatase assay kit 
uses pNPP (p-Nitrophenyl phosphate) as a colorimetric substrate for alkaline phosphatase-
based ELISA secondary antibody detection systems. The procedure included pipetting 
100µl of each sample into 96-well plates. 50µl of buffer solution (AMP-pNPP-MgCl2) were 
added to each well and the plates were incubated at 37ºC until a change in color was noted 
in the majority of wells taking into account that the total incubation does not exceed 3 hours. 
The reaction was then stopped by adding 100µl of NaOH and the plates were read using an 
absorbance mircoplate reader detecting the absorbance at 405nm. The samples were then 
compared to the standards prepared in the same assay. The levels of osteocalcin in the 
conditioned media were assayed with the use of a commercially available enzyme-linked 
immunoassay kit (IBL GmbH, Hamburg; Immundiagnostik AG, Bensheim; Germany) where 
25µl of standards, controls and samples were pipetted in 96-well-microplates. 125µl of anti-
osteocalcin antibody were added to each well. The plates were then incubated at room 
temperature for 2 hours. Afterwards, all wells were washed three times using 300µl/well of 
the washing solution provided with the kit. Thereafter, 150µl/well enzyme conjugate were 
added and the plates were incubated at room temperature for 1 hour. 150µl substrate 
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solution was added to each well and the plates were left at room temperature for another 40 
minutes. 50µl/well stop solution was then added and the plates were read within 15 minutes 
using an absorbance mircoplate reader detecting the absorbance at 405nm. 
 
Statistical Analysis 
For any given experiment the mean ± SEM of 6 independent cultures was calculated. 
Variance and statistical significance of data were analyzed by Bonferroni's modification of 
Student's t-test. P-values < 0.05 were considered to be significant. Each set of experiments 
was repeated twice and analyzed separately. Both sets of experiments had comparable 
results; hence the results of only one of the two sets are presented. 
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Results 
Alkaline phosphatase and Osteocalcin were detectable in both first and fourth passage 
cells. When first and fourth passage PDL cells were cultured for five days in the absence of 
FGF-2 or BMP-7, cell number and alkaline phosphatase specific activity were higher in first 
passage cells, whereas osteocalcin production was higher in fourth passge cells (Fig. 4, 
Fig. 5, Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Proliferation of PDL cells of the first and fourth passage with and without treatment with FGF-
2 and BMP-7. Data were acquired from one of two separate experiments, both yielding comparable 
results. Each value is the mean ± standard error of the mean for six independent cultures. *p < 0.05, 
experimental group vs. vehicle-treated control within the same passage; #p < 0.05, experimental 
group vs. fibroblast growth factor-2- treated group within the same cell passage; ●p < 0.05, 
particular group vs. same treatment regime in first passage cells. BMP-7, bone morphogenetic 
protein-7; FGF-2, fibroblast growth factor-2. 
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Fig. 5: ALP specific activity of PDL cells of the first and fourth passage with and without treatment 
with FGF-2 and BMP-7. Data were acquired from one of two separate experiments, both yielding 
comparable results. Each value is the mean ± standard error of the mean for six independent 
cultures. *p < 0.05, experimental group vs. vehicle-treated control within the same passage; #p < 
0.05, experimental group vs. fibroblast growth factor-2- treated group within the same cell passage; 
●p < 0.05, particular group vs. same treatment regime in first passage cells. BMP-7, bone 
morphogenetic protein-7; FGF-2, fibroblast growth factor-2. 
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Fig. 6: Osteocalcin production of PDL cells of the first and fourth passage with and without 
treatment with FGF-2 and BMP-7. Data were acquired from one of two separate experiments, both 
yielding comparable results. Each value is the mean ± standard error of the mean for six 
independent cultures. *p < 0.05, experimental group vs. vehicle-treated control within the same 
passage; #p < 0.05, experimental group vs. fibroblast growth factor-2- treated group within the same 
cell passage; ●p < 0.05, particular group vs. same treatment regime in first passage cells. BMP-7, 
bone morphogenetic protein-7; FGF-2, fibroblast growth factor-2. 
 
 
Exposing PDL cells to FGF-2 led to an increase in cell number. This effect displayed just a 
trend without statistical significance and was more prominent in cells of the 1st passage 
than in those of the 4th one (Fig. 4).  
Similar effects were observed in the dermal and osteoblast reference cell lines where FGF-
2 evoked a statistically significant increase in cell number in both dermal fibroblasts, with an 
increase of almost 131%, and in MG63 cells with an average increase of 46% (Fig. 7, Fig. 
8).  
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Fig. 7: Effect of FGF-2 and BMP-7 administration for five days on the proliferation of DF cells. Data 
were acquired from one of two separate experiments, both yielding comparable results. Each value 
is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. same group after 5 
days in culture; #P<0.05, particular group vs. same group of the preceding culture period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Effect of FGF-2 and BMP-7 administration for five days on the proliferation of MG63 cells. 
Data were acquired from one of two separate experiments, both yielding comparable results. Each 
value is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. same group after 
5 days in culture; #P<0.05, particular group vs. same group of the preceding culture period. 
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The opposite was observed after treating PDL cells with BMP-7 where a statistically 
significant reduction in cell number resulted. This reduction was seen in both passages but 
was more evident in 4th passage cells with an average decrease of 43% (Fig. 4). 
A statistically significant reduction in cell number was also seen in dermal fibroblasts and 
MG63 cells with an average of 23% and 10.3%, respectively (Fig.  7, Fig. 8). 
 
Regarding the differentiation parameters, PDL cells of the 1st passage showed no 
difference in the ALP activity following treatment with FGF-2. A slight, statistically 
nonsignificant increase was seen in cells of the 4th passage and a similar trend was seen in 
the DF cells (Fig. 5, Fig. 9). In contrast, a statistically significant increase which averaged 
about 110% was seen in the ALP activity in MG63 cells (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9: Effect of FGF-2 and BMP-7 administration for five days on the ALP specific activity of DF 
cells. Data were acquired from one of two separate experiments, both yielding comparable results. 
Each value is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. same group 
after 5 days in culture; #P<0.05, particular group vs. same group of the preceding culture period. 
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Fig. 10: Effect of FGF-2 and BMP-7 administration for five days on the ALP specific activity of MG63 
cells. Data were acquired from one of two separate experiments, both yielding comparable results. 
Each value is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. same group 
after 5 days in culture; #P<0.05, particular group vs. same group of the preceding culture period. 
 
 
Unlike FGF-2, an increase in ALP activity of PDL cells was triggered by BMP-7 regardless 
of the passage whereas a statistically significant more pronounced effect was detected in 
cells of the 4th passage where the ALP activity increased by about 300% (Fig. 5). 
 
An opposite effect was observed in MG63 cells where a reduction of 21% in treated cells in 
comparison to the controls was noticed (Fig. 10). In dermal fibroblasts basal expression of 
ALP specific activity was very low and remained unaffected by BMP-7 (Fig. 9) 
 
The unchanged ALP activity of PDL cells of the 1st passage after being treated with FGF-2 
was accompanied by a slight increase in osteocalcin production. In contrast, cells of the 4th 
passage showed a slight decrease (Fig. 6). 
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In this aspect, PDL cells of the 4th passage were comparable to MG63 cells which also 
showed a statistically nonsignificant reduction in osteocalcin production after exposure to 
FGF-2 (Fig. 11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Effect of FGF-2 and BMP-7 administration for five days on the osteocalcin production of 
MG63 cells. Data were acquired from one of two separate experiments, both yielding comparable 
results. Each value is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. 
same group after 5 days in culture; #P<0.05, particular group vs. same group of the preceding 
culture period 
 
 
 
 
 
 
  
21
DF cells exhibited a very low production of osteocalcin that was hardly influenced by the 
administration of FGF-2 (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Effect of FGF-2 and BMP-7 administration for five days on the osteocalcin production of DF 
cells. Data were acquired from one of two separate experiments, both yielding comparable results. 
Each value is the mean ± SEM for 6 independent cultures. *P<0.05, particular group vs. same group 
after 5 days in culture; #P<0.05, particular group vs. same group of the preceding culture period 
 
 
Treating PDL cells with BMP-7 resulted in a statistically significant increase in osteocalcin 
production in both 1st and 4th passage cells with an average increase of 37% and 80% 
respectively (Fig. 6). A similar effect was noticed after treating MG63 cells with BMP-7 (Fig. 
11). In dermal fibroblasts basal expression of osteocalcin was very low and remained 
unaffected by BMP-7 (Fig. 12). 
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Discussion 
In this study, the effect of a FGF-2 and BMP-7-simulation on the phenotypic expression of 
human PDL cells with special attention directed to the role of cellular developmental age 
was examined. The cellular response was compared to a dermal and to an osteoblastic 
reference cell line. 
 
Proliferation was measured using a cell counter (Moelab, Hilgen, Germany) allowing for 
determination of cell number as well as the differentiation parameters within the same 
experiment. The cell number was used as an indicator of proliferation in our experiment. 
The ratio of proliferation versus apoptosis was not further investigated. Changes in 
differentiation on the other hand were assessed using two parameters, osteocalcin and 
alkaline phosphatase content in the conditioned medium. 
 
Alkaline phosphatase (ALP) is one of the most widely recognized biochemical markers for 
early osteoblast differentiation (Sabokbar et al. 1994). The osteocalcin immunoassay 
quantitatively measures intact osteocalcin in collected medium. Osteocalcin studies in 
developing embryos and bone cell models have validated its high specificity as a marker for 
the mature osteoblastic phenotype. As osteocalcin is expressed by osteoblasts, it is often 
used as a biochemical marker for the bone formation process (Gomez et al. 1994, Delmas 
1995).  
The ELISA allows for a quantitative assessment. Since data was expressed as a function of 
cell number it was assured that changes actually result from changes in the expression by 
single cells and not just from an increase in cell number. 
 
The characteristics of PDL cells and their response to different stimuli were compared to a 
dermal and to an osteoblastic reference cell line in order to verify whether the phenotype 
resembles more that of dermal fibroblasts or osteoblasts and whether it could be altered 
towards fibroblasts or osteoblasts after treatment with FGF-2/BMP-7. 
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Different models of cellular developmental age have been used previously. Some studies 
have used cells at different stages of confluence as a model for cellular maturation 
(Lossdörfer et al. 2005, Lossdörfer et al. 2006a, 2006b, 2006c). In our study, cell passage 
was used. However, it is not clear whether the PDL cells of a higher passage actually 
display a more mature phenotype than those of a lower passage and whether the results of 
such an experimental setup can be compared to those obtained from experiments with 
different states of confluence.  Lossdörfer and co-workers (2006) have reported increased 
alkaline phosphatase specific activity and osteocalcin production in confluent PDL cells 
compared with lower levels in pre-confluent cultures indicating a more mature phenotype of 
confluent cells. It is unclear whether these distinct differences hold true for different cell 
passages as well. 
 
In this study, the proliferative activity of PDL cells decreased with cellular developmental 
age. This decrease was accompanied by an increase of osteocalcin production indicating 
the differentiation towards a more mature osteoblast phenotype. These findings are 
coincident with results obtained from earlier experiments done in our laboratory where PDL 
cells that were cultured for up to 3 weeks showed an increase in differentiation and a 
decrease in mitogenic activity with time (Lossdörfer et al. 2008). An early gene expression 
for alkaline phosphatase and a later Osteocalcin expression was also observed in bone 
marrow stromal cells (Huang 2004) and differentiating rat osteoblasts that were cultured for 
up to four weeks (Owen 1990). 
 
Proliferation and alkaline phosphatase specific activity were stronger in first passage cells 
as compared to fourth passage cells. Apparently, cells of lower passages exhibit a stronger 
proliferative potential than those of higher cell passages. This conclusion is supported by 
data comparing the expression of molecules associated with tissue mineralization in freshly 
isolated PDL tissue and PDL cells in culture where fresh PDL cells expressed larger 
quantities of periostin, osteopontin and alkaline phosphatase activity (Lallier and Spencer 
2007). An early gene expression for alkaline phosphatase and later osteocalcin expression 
was observed in bone marrow stromal cells (Huang et al. 2004) and differentiating rat 
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osteoblasts (Owen et al. 1990, Thomas et al. 2001) that were cultured for up to four weeks. 
Sawa and coworkers observed a reduction in ALP activity in aged human osteogenic PDL 
fibroblasts (Sawa et al. 2004) whereas an increase of ALP activity with time was reported in 
another study (Basdra and Komposch 1997). This conflicting data could be explained by 
the fact that Sawa and coworkers have used human fibroblasts from donors aging between 
15 to 51 years.  
  
Regarding the effect of growth factors on PDL cell proliferation and differentiation, FGF- 2 
increased the proliferative activity without changing alkaline phosphatase activity in both 
first and fourth passage cells. A similar enhancement of proliferation after treating PDL cells 
with FGF-2 was also reported in other studies (Zhang et al. 2001, Ling and Li 2004). 
Yamada and coworkers (2006) have confirmed that the addition of FGF-2 to a long-term 
human PDL cell culture resulted in a down-regulation of ALP activity. An increase of 
proliferation and a down regulation of ALP activity were also reported by Takayama and 
coworkers (Takayama et al. 1997). Ge and Yang (2001) have reported an increase of 
proliferation with an inhibition of cytodifferentiation of PDL cells after FGF-2 treatment. 
On the other hand, the osteocalcin content increased significantly after the administration of 
FGF-2. This is in line with results reported by Tirashima and coworkers (2008) who 
investigated the effect of FGFs on the periodontal ligament in a mouse model and found 
that FGF-2 induces a unique expression of another marker of differentiation namely 
osteopontin, which increased with the progression of PDL cell differentiation. Similar results 
were observed when using exogenous FGF-5 (Lallier and Spencer 2007).  
In vitro studies showing an inhibitory effect of FGF-2 on PDL cell maturation seem to be 
contradictory to the in vivo trials demonstrating that topical application of exogenous FGF-2 
enhanced periodontal regeneration in experimental bony defects (Murakami et al. 1999). 
Given the pro-mitogenic effect of FGF-2 opposing its inhibitory actions on differentiation, 
these data might be interpreted in terms of a role for FGF-2 in maintaining a pool of PDL 
cells in a multipotent, naive state that might later on be directed to differentiate by other 
factors in the local microenvironment. In fact, a high density of immature cells was 
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recognized histologically after the application of FGF-2 to bone defects in beagle dogs 
(Murakami et al. 1999).  
 
Administrating FGF-2 to dermal fibroblasts led to a significant increase of their proliferation. 
The same was noticed in a study done by Root and Shipley (1991).  
Dermal fibroblasts displayed a very low level of alkaline phosphatase activity that was 
hardly influenced by treatment with FGF-2. Similar results were shown by Whyte and co-
workers (1987). The osteocalcin production of dermal fibroblasts was also minimal and was 
not affected by treatment with FGF-2 in our study. No information in the literature could be 
found on the expression of osteocalcin by dermal fibroblast and the effect of FGF-2 on this 
parameter. 
 
In MG63 cells, FGF-2 induced an increase of proliferative activity. This was also reported in 
other studies (Kim et al. 2007, Takechi 2008).  Alkaline phosphatase specific activity 
increased significantly. A similar effect was reported in another study in which the addition 
of FGF-8 to mouse bone marrow cultures effectively increased initial cell proliferation as 
well as subsequent osteoblast-specific alkaline phosphatase production (Valta et al. 2006) 
 
BMP-7 suppressed the proliferation but induced PDL cells to assume a more differentiated 
phenotype in our experiments. This effect was more pronounced in fourth passage cells. 
Lallier and Spencer (2007) also reported an enhanced alkaline phosphatase activity 
following BMP-7 exposure of PDL cells. Besides BMP-7, other BMPs were shown to 
promote osteoblastic differentiation of human PDL cells while inhibiting their proliferation 
(Markopoulou 2003). They also induced an increase in the expression of osteopontin, 
alkaline phosphatase (Xu et al. 2004), and osteocalcin (Yamada et al. 2006) committing 
them to differentiate towards the osteo-cementoblastic phenotype (Kobayashi et al. 1999, 
Zhao et al. 2002).   
 
Adding BMP-7 to dermal fibroblasts significantly suppressed their proliferation in contrast to 
another study in which the role of BMP-2 in normal skin development and fetal wound 
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healing in fetal mammals was investigated (Stelnicki 1998). In that study, BMP-2 induced 
massive dermal and epidermal growth when compared with controls. This difference could 
have resulted from the use of BMP-2 in fetal mammals as it was the case in the study of 
Stelnicki. Support for the physiological relevance of the in vitro findings was provided by the 
demonstration of an involvement of BMP-7 with the stimulation of periodontal regeneration 
in animal models (Taba et al. 2005).  
 
In conclusion, according to the present investigation, PDL cells displayed greater similarity 
to osteoblasts than to dermal fibroblasts, possibly reflecting their common origin (the neural 
crest). Both FGF-2 and BMP-7 demonstrate their potential in periodontal regeneration by a 
different mode of action on PDL cells with FGF-2 maintaining a pool of multipotent cells that 
might be committed to osteoblastic differentiation by BMP-7 and other local factors. 
 
In summary the present study adds to a better characterization of the PDL cell phenotype 
and points out the critical role of cell passage in this respect. The data provide a theoretical 
basis which is crucial for the development of promising strategies to influence the 
differentiation process of PDL cells and aid periodontal repair processes following 
periodontal disease or orthodontic tooth movement. 
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Summary 
Although periodontal ligament cells (PDL) display several osteoblastic traits, their 
phenotypic expression is still not well-established. It remains a matter of debate whether 
they resemble a terminally differentiated cell type or an intermediate maturation state which 
potentially can be directed towards a fibroblastic or osteoblastic phenotype. To further 
explore the PDL cells’ characteristics, first and fourth passage human PDL cells were used. 
Cell number was determined using a cell counter. Alkaline-phosphatase-specific activity 
was measured in lysates of isolated cells and the levels of osteocalcin in the conditioned 
media were assayed with the use of a commercially available enzyme-linked immunoassay 
kit. Furthermore, the cellular response to FGF-2 and BMP-7 was examined in first and 
fourth passage cells. Dermal fibroblasts and osteoblast-like cells (MG63) served as 
reference cell lines. 
Proliferation decreased over time and was highest in first passage cells. The expression of 
differentiation parameters increased with culture time and was higher in first passage cells 
than in the fourth one. FGF-2 administration enhanced cell numbers in both passages 
whereas ALP and osteocalcin production remained unchanged. In contrast, BMP-7 
exposure of PDL cells resulted in a reduction of cell number in both passages while ALP 
and osteocalcin production were enhanced. In dermal fibroblasts, differentiation parameters 
did not respond to both stimuli. MG63 cells behaved similarly to PDL cells. These results 
indicate that subcultivation affects the phenotypic expression of human PDL cells with 
respect to characteristics that these cells share with osteoblasts. Furthermore, the PDL cell 
phenotype can be altered by fibroblastic and osteoblastic growth factors. 
 
 
 
 
 
 
 
  
28
Literaturverzeichnis 
 
Basdra EK, Komposch G. Osteoblast-like properties of human periodontal ligament cells: 
an in vitro analysis. Eur J Orthod 1997; 19: 615-621 
 
Bretaudiere JP, Spillman T. Alkaline phosphatases. In: Bergmeyer HU (ed) Methods of 
Enzymatic Analysis. Weinheim, Germany: Verlag Chemica, 1984: 75-92. 
 
Chen FP, Lee N, Wang KC, Soong YK, Huang KE. Effect of estrogen and 1alpha,25(OH)2- 
vitamin D3 on the activity and growth of human primary osteoblast-like cells in vitro. Fertil 
Steril 2002; 77: 1038-1043 
 
Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D. Of worms and men: 
an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor 
families. J Mol Evol 1997; 44: 43-56 
 
Delmas PD. Biochemical markers of bone turnover. Acta Orthop Scand Suppl 1995; 266: 
176-182 
 
Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. Gene therapy for bone formation: 
in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 
2000; 78: 476-486 
 
Hankemeier S, Keus M, Zeichen J, Jagodzinski M, Barkhausen T, Bosch U. Modulation of 
proliferation and differentiation of human bone marrow stromal cells by fibroblast growth 
factor 2: potential implications for tissue engineering of tendons and ligaments. Tissue Eng 
2005; 11: 41-49 
 
Hou LT, Li TI, Liu CM, Liu BY, Liu CL, Mi HW. Modulation of osteogenic potential by 
recombinant human bone morphogenic protein-2 in human periodontal ligament cells: effect 
of serum, culture medium, and osteoinductive medium. J Periodontal Res 2007; 42: 244-
252 
 
Huang CY, Reuben PM, D'Ippolito G, Schiller PC, Cheung HS. Chondrogenesis of human 
bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol 
Cell Evol Biol 2004; 278: 428-436 
 
Jackson RA, Nurcombe V, Cool SM. Coordinated fibroblast growth factor and heparan 
sulfate regulation of osteogenesis. Gene 2006; 379: 79-91 
 
Kim JB, Leucht P, Luppen CA, Park YJ, Beggs HE, Damsky CH. Reconciling the roles of 
FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration. Bone 
2007; 41: 39-51 
 
  
29
Kobayashi M, Takiguchi T, Suzuki R, Yamaguchi A, Deguchi K, Shionome M. Recombinant 
human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated 
from human periodontal ligament. J Dent Res 1999; 78: 1624-1633 
 
Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: 
BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 2000; 11: 1201-
1210 
 
Lallier TE, Spencer A. Use of microarrays to find novel regulators of periodontal ligament 
fibroblast differentiation. Cell Tissue Res 2007; 327: 93-109 
 
Lekic P, Rojas J, Birek C, Tenenbaum H, McCulloch CA. Phenotypic comparison of 
periodontal ligament cells in vivo and in vitro. J Periodontal Res 2001; 36: 71-79 
 
Ling JQ, Li JP. Insulin-like growth factor-II and basic fibroblast growth factor affect 
periodontal ligament cells expressing osteoprotegerin in vitro. Hua Xi Kou Qiang Yi Xue Za 
Zhi 2004; 22: 366-369 
 
Lossdorfer S, Gotz W, Jager A. PTH(1-34) affects osteoprotegerin production in human 
PDL cells in vitro. J Dent Res 2005; 84: 634-638 
 
Lossdorfer S, Gotz W, Jager A. Parathyroid hormone modifies human periodontal ligament 
cell proliferation and survival in vitro. J Periodontal Res 2006a; 41: 519-526 
 
Lossdorfer S, Gotz W, Rath-Deschner B, Jager A. Parathyroid hormone(1-34) mediates 
proliferative and apoptotic signaling in human periodontal ligament cells in vitro via protein 
kinase C-dependent and protein kinase A-dependent pathways. Cell Tissue Res 2006b; 
325: 469-479 
 
Lossdorfer S, Stier S, Gotz W, Jager A. Maturation-state dependent response of human 
periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro. J 
Periodontal Res 2006c; 41: 62-72 
 
Lossdorfer S, Fiekens D, Salik MI, Gotz W, Jager A. Subculture affects the phenotypic 
expression of human periodontal ligament cells and their response to fibroblast growth 
factor-2 and bone morphogenetic protein-7 in vitro. J Periodontal Res 2008; 43: 563-569 
 
Markopoulou CE, Vrotsos IA, Vavouraki HN, Dereka XE, Mantzavinos ZS. Human 
periodontal ligament cell responses to recombinant human bone morphogenetic protein-2 
with and without bone allografts. J Periodontol 2003; 74: 982-989 
 
Murakami S, Takayama S, Ikezawa K, Shimabukuro Y, Kitamura M, Nozaki T. 
Regeneration of periodontal tissues by basic fibroblast growth factor. J Periodontal Res 
1999; 34: 425-430 
  
30
Nakashima M, Reddi AH. The application of bone morphogenetic proteins to dental tissue 
engineering. Nat Biotechnol 2003; 21: 1025-1032 
 
Okamoto T, Yatsuzuka N, Tanaka Y, Kan M, Yamanaka T, Sakamoto A. Growth and 
differentiation of periodontal ligament-derived cells in serum-free defined culture. In Vitro 
Cell Dev Biol Anim 1997; 33: 302-309 
 
Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS. Progressive 
development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression 
of genes associated with osteoblast proliferation and differentiation during formation of the 
bone extracellular matrix. J Cell Physiol 1990; 143: 420-430 
 
Ripamonti U, Heliotis M, Rueger DC, Sampath TK. Induction of cementogenesis by 
recombinant human osteogenic protein-1 (hop-1/bmp-7) in the baboon (Papio ursinus). 
Arch Oral Biol 1996; 41: 121-126 
 
Ripamonti U, Reddi AH. Tissue engineering, morphogenesis, and regeneration of the 
periodontal tissues by bone morphogenetic proteins. Crit Rev Oral Biol Med 1997; 8: 154-
163 
 
Root LL, Shipley GD. Human dermal fibroblasts express multiple bFGF and aFGF proteins. 
In Vitro Cell Dev Biol 1991; 27A: 815-822 
 
Sabokbar A, Millett PJ, Myer B, Rushton N. A rapid, quantitative assay for measuring 
alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner 1994; 27: 57-67 
 
Sawa Y, Yamaoka Y, Kuroshima S, Yoshida S. Reduction of alkaline phosphatase activity 
in aged human osteogenic periodontal ligament fibroblasts exhibiting short telomeres. Cell 
Tissue Res 2004; 315: 331-337 
 
Stelnicki EJ, Longaker MT, Holmes D, Vanderwall K, Harrison MR, Largman C. Bone 
morphogenetic protein-2 induces scar formation and skin maturation in the second trimester 
fetus. Plast Reconstr Surg 1998; 101: 12-19 
 
Taba M, Jr., Jin Q, Sugai JV, Giannobile WV. Current concepts in periodontal 
bioengineering. Orthod Craniofac Res 2005; 8: 292-302 
 
Takayama S, Murakami S, Miki Y, Ikezawa K, Tasaka S, Terashima A. Effects of basic 
fibroblast growth factor on human periodontal ligament cells. J Periodontal Res 1997; 32: 
667-675 
 
Takayama S, Yoshida J, Hirano H, Okada H, Murakami S. Effects of basic fibroblast growth 
factor on human gingival epithelial cells. J Periodontol 2002; 73: 1467-1473 
  
31
Takechi M, Tatehara S, Satomura K, Fujisawa K, Nagayama M. Effect of FGF-2 and 
melatonin on implant bone healing: a histomorphometric study. J Mater Sci Mater Med 
2008; 19: 2949-2952 
 
Terashima Y, Shimabukuro Y, Terashima H, Ozasa M, Terakura M, Ikezawa K. Fibroblast 
growth factor-2 regulates expression of osteopontin in periodontal ligament cells. J Cell 
Physiol 2008; 216: 640-650 
 
Thomas GP, Baker SU, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA 
expression in differentiating murine primary osteoblasts. J Endocrinol 2001; 170: 451-460 
 
Valta MP, Hentunen T, Qu Q, Valve EM, Harjula A, Seppanen JA. Regulation of osteoblast 
differentiation: a novel function for fibroblast growth factor 8. Endocrinology 2006; 147: 
2171-2182 
 
Waddington RJ, Embery G. Proteoglycans and orthodontic tooth movement. J Orthod 2001; 
28: 281-290 
 
Wang IE, Shan J, Choi R, Oh S, Kepler CK, Chen FH. Role of osteoblast-fibroblast 
interactions in the formation of the ligament-to-bone interface. J Orthop Res 2007; 25: 
1609-1620 
 
Wescott DC, Pinkerton MN, Gaffey BJ, Beggs KT, Milne TJ, Meikle MC. Osteogenic gene 
expression by human periodontal ligament cells under cyclic tension. J Dent Res 2007; 86: 
1212-1216 
 
Whyte MP, Rettinger SD, Vrabel LA. Infantile hypophosphatasia: enzymatic defect explored 
with alkaline phosphatase-deficient skin fibroblasts in culture. Calcif Tissue Int 1987; 40: 
244-252 
 
Xu WP, Shiba H, Mizuno N, Uchida Y, Mouri Y, Kawaguchi H. Effect of bone 
morphogenetic proteins-4, -5 and -6 on DNA synthesis and expression of bone-related 
proteins in cultured human periodontal ligament cells. Cell Biol Int 2004; 28: 675-682 
 
Yamada S, Ozawa Y, Tomoeda M, Matoba R, Matsubara K, Murakami S. Regulation of 
PLAP-1 expression in periodontal ligament cells. J Dent Res 2006; 85: 447-451 
 
Zhang SJ, Liang YH, Yang PS. Effects of basic fibroblast growth factor on growth of human 
periodontal ligament cells. Shanghai Kou Qiang Yi Xue 2001; 10: 135-137 
 
Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ. Bone morphogenetic 
protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast 
phenotype. J Bone Miner Res 2002; 17: 1441-1451 
 
  
32
Danksagung 
Mein größter Dank gebührt Gott der mir die Fähigkeit gegeben hat diese Arbeit 
durchzuführen. Für meine Doktorarbeit schulde ich aber auch vielen Menschen einen 
herzlichen Dank. Besonders möchte ich mich bei meinem Doktorvater PD. Dr. Stefan 
Lossdörfer bedanken, denn er brachte mir sehr viel Geduld entgegen und sorgte mit 
wertvollen Ratschlägen für das Gelingen der Arbeit. Des Weiteren möchte ich mich bei 
meinen Eltern bedanken, ohne die weder ein Studium noch eine Doktorarbeit jemals 
möglich geworden wären. Ein großer Dank geht auch an meinen Chef Prof. Dr. Jäger, da er 
mir mit seinem fundierten Fachwissen viele Anregungen für meine wissenschaftliche Arbeit 
gab. Zuletzt  möchte ich mich bei Frau Reifenrath für ihre Hilfe ganz herzlich bedanken. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
